[1] [5] Patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should discuss these conditions with their healthcare provider, as GLP-1 receptor agonists have been associated with thyroid C-cell tumours in animal studies
Pro-inflammatory cytokines (e.g., IL-1 and TNF), mediators of Th1 and Th17 cells (e.g., IFN and IL-17), and effector mechanisms involving neutrophils, macrophages, and plasma cells are all implicated in the disease process [28, 29]
Activation of these receptors directly stimulates nausea pathways, particularly during initiation and dose escalation phases
JAMA (2019) 321:1457
The STEP trials, which enrolled over 4,500 participants, showed that semaglutide produced average weight loss of 1522% of body weight over 68 weeks, compared to 23% with placebo and lifestyle intervention alone
That's the basic idea